Our retrospective cohort of 129 NSCLC patients revealed 17 (13.2%) carrying BRCA1/2 mutations, five carrying germline HR gene mutations, and 33 carrying somatic HR gene mutations. Here, BRCA1 is linked to non-small cell lung carcinoma.